scispace - formally typeset
T

Tom Van Belle

Researcher at Katholieke Universiteit Leuven

Publications -  26
Citations -  2198

Tom Van Belle is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Immune system & CD8. The author has an hindex of 18, co-authored 26 publications receiving 1993 citations. Previous affiliations of Tom Van Belle include Flanders Institute for Biotechnology & The Catholic University of America.

Papers
More filters
Journal ArticleDOI

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

TL;DR: The genetic, environmental, and immunological data underlying the prevention and intervention strategies to constrain T1D are explained, including the efficacy of antigen-specific and antigen-nonspecific immune interventions.
Journal ArticleDOI

Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice

TL;DR: It is shown that combination therapy with low-dose systemic anti-CD3 stably reverted diabetes in NOD mice and increased frequencies of local Tregs, which not only accumulated in the pancreatic islets, but also suppressed immune response in an autoantigen-specific way, allowing reversal of established autoimmune diabetes.
Journal ArticleDOI

Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice

TL;DR: This work provides demonstration of the essential prodiabetogenic activities of IL-21 on diverse genetic backgrounds (NOD and C57BL/6) and indicates that IL- 21 blockade could be a promising strategy for interventions in human type 1 diabetes.
Journal ArticleDOI

Vitamin D in autoimmune, infectious and allergic diseases: a vital player?

TL;DR: The genetic and epidemiologic data potentially linking vitamin D to autoimmune, infectious and allergic diseases are summarized and how vitamin D influences the immune responses in each of those conditions is discussed based on the data generated using patient samples or preclinical models of each of these diseases.
Journal ArticleDOI

Oral Delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis Reverses Diabetes in Recent-Onset NOD Mice

TL;DR: This treatment stabilized insulitis, preserved functional β-cell mass, and restored normoglycemia in recent-onset NOD mice, even when hyperglycemia was severe at diagnosis, and indicates a great therapeutic potential of orally administered autoantigen-secreting LL for tolerance induction in T1D.